ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

COR vs JNJ // GROSS PROFIT MARGIN

Cencora Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: COR 5 — JNJ 10
▲ GROSS PROFIT MARGIN LEADER: JNJ
gross-margins
3.60%
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COR VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC COR JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 3.60% 67.90% -64.30 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 26.80% 25.50% +1.30 COR /roic <GO>
EV/EBITDA & P/E Valuation 21.6x 18.5x +3.10 JNJ /valuation <GO>
Free Cash Flow Yield 5.08% 2.97% +2.11 COR /fcf-yield <GO>
Operating Margin 0.80% 34.70% -33.90 JNJ /operating-margins <GO>
Net Profit Margin 0.50% 28.50% -28.00 JNJ /net-margins <GO>
Revenue Growth (YoY) 9.30% 6.00% +3.30 COR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.69% 0.00% +0.69 COR /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.27 5.59 -0.32 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.50% 7.20% -0.70 COR /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.1 60.4 -6.21 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.88 1.08 -0.20 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 37.8x 23.0x +14.80 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $63.07B $662.49B -$599.42B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR COR REV JNJ REV COR GROSS % JNJ GROSS % COR FCF JNJ FCF
FY 2025 $321.33B $94.19B 3.6% 67.9% $3.21B $19.70B
FY 2024 $293.96B $88.82B 3.4% 69.1% $3.00B $19.84B
FY 2023 $262.17B $85.16B 44.0% 44.0% -$7.89B $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COR // BETA 0.88
JNJ // BETA 1.08